Scientists at Texas Biomed develop new tool to aid in the development of SARS-CoV-2 antivirals and vaccines
Texas Biomedical Research InstituteResearchers apply a novel reverse genetics approach to create recombinant SARS-CoV-2San Antonio, Texas (October 1, 2020) – Researchers at Texas Biomedical Research Institute (Texas Biomed) recently published findings from an innovative SARS-CoV-2 study that will assist in the development of new vaccines and antivirals for COVID-19.